The most recent issue of the Diseases of the Colon & Rectum investigates optimal surveillance protocols after curative resection in patients with stage IV colorectal cancer.
The most recent issue of the Clinical Gastroenterology & Hepatology examines the use of biologic therapy by pregnant women with inflammatory bowel disease does not affect infant response to vaccines.
The latest issue of the Alimentary Pharmacology & Therapeutics examines outpatient IBD drug utilization trends, relative market share, and costs in the USA during a 9-year period.
The latest Alimentary Pharmacology & Therapeutics evaluates relationships between single nucleotide polymorphisms, and reflux symptom burden, GERD phenotypes from ambulatory reflux monitoring, and quality of life.
This month's Diseases of the Colon & Rectum reports on the fatty liver index as a simple and accurate predictor of colorectal adenoma in an average-risk population.
This month's issue of Gastroenterology directly compares the diagnostic performance of 9 quantitative fecal immunochemical tests for colorectal cancer screening.
January's issue of the Alimentary Pharmacology & Therapeutics identifies risk factors for biopsy-proven advanced non-alcoholic fatty liver disease in the Veterans Health Administration.
A study in the most recent issue of the Clinical Gastroenterology & Hepatology examines the prevalence of dyspepsia in individuals with gastroesophageal reflux–type symptoms in the community.
This month's issue of Gastroenterology examines cost effectiveness of age-specific screening intervals for people with family histories of colorectal cancer.
The most recent issue of the Diseases of the Colon & Rectum examines associations between cancer-related financial stress and strain and health-related quality of life.
The latest issue of the Liver International reports that the improvement of diagnostic approaches and optimization of current therapy rank highest on the research agenda for autoimmune hepatitis.
Colectomy prior to diagnosis of primary sclerosing cholangitis is associated with improved prognosis in a nationwide cohort study reported in the latest issue of the Alimentary Pharmacology & Therapeutics.
Aprepitant has mixed effects on nausea and reduces other symptoms in patients with gastroparesis and related disorders, reports January's issue of Gastroenterology.
Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.
By continuing to browse this site you agree to us using cookies as described in our
standard cookie policy .